The performance of AAV gene-therapy vectors is studied in machine-perfused human livers — and the presence of fatty liver disease makes a difference.

Click ‘Submit manuscript’ and you will be taken to our online submission system, where you can upload the required files and check on the status of your manuscript after submission. You will ...

Nature Biotechnology is interested in the best research from across the field of Biotechnology; our broad scope ensures that work published reaches the widest possible audience. All editorial ...

Like the other Nature titles, Nature Biotechnology has no external editorial board. Instead, all editorial decisions are made by a dedicated team of professional editors with relevant research and ...

Springer Nature is a signatory of the San Francisco Declaration on Research Assessment (DORA). Because small numbers of highly cited articles can have outsized influence on certain citation ...

If you are unsure whether your paper is in scope for Nature Biotechnology, you can submit a presubmission enquiry, providing an abstract of your work. You can do this in our online Manuscript ...

Nature Biotechnology is a monthly journal covering the science and business of biotechnology. It publishes new concepts in technology/methodology of relevance to the biological, biomedical ...

The Methods section should be written as concisely as possible but should contain all elements necessary to allow interpretation and replication of the results. The Methods sections of all ...

Nature Biotechnology is a monthly journal publishing new concepts in biological technology of relevance to bioengineering, medicine, energy, agriculture, food and the environment. It has a ...

Nature Biotechnology provides its latest table of contents as an RSS web feed, so you can get the world's best science delivered straight to your desktop. Receive Nature Biotechnology's current ...

Researchers should be free to pursue lines of inquiry and the communication of knowledge and ideas without fear of repression or censorship. At the same time, they have the ethical obligation to ...

Society, patients and clinicians welcome a much-needed non-opioid pain medication. Vertex’s first-in-class analgesic Journavx could soon be followed by a new generation of addiction-free pain ...